I don't think that there are any studies that show that fibrates reduce the risk of coronary artery disease, despite improvement in lipid markers. And of course we are most interested in outcomes, not "surrogate" results of blood tests.
I could be wrong, but I thought Attia and Dayspring addressed this in their podcast. Didn't they indicate that there had been problems with the studies done to date? I thought they did recommend fibrates or Ezetimibe alone for folks who couldn't tolerate a statin. If true (listen to the section about statins and cognition), this may be an option for you until you can adequately address your insulin resistance. Best of luck, blade. Keep us posted on your progress.